Santa Cruz Biotechnology now offers a broad range of cyclin A Inhibitors. Drosophila cyclin A and B both regulate the cyclin dependent kinase cdc2 with cyclin A expression peaking in prophase, while cyclin B expression peaks until metaphase. cyclin A Inhibitors offered by Santa Cruz inhibit cyclin A and, in some cases, other cell cycle and cyclin dependent kinase related proteins. View detailed cyclin A Inhibitor specifications, including cyclin A Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 21 to 23 of 23 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CR8, (S)-Isomer | 1084893-56-0 | sc-311307 | 5 mg | $201.00 | ||
CR8, (S)-Isomer, with CAS 1084893-56-0, is a chemical compound known for its role as a cyclin A inhibitor. It influences cellular processes by targeting cyclin A, a key protein involved in cell cycle regulation. The compound's interaction with cyclin A contributes to its biological activity, impacting cell cycle dynamics. | ||||||
PHA-793887 | 718630-59-2 | sc-364580 sc-364580A | 5 mg 10 mg | $189.00 $432.00 | ||
PHA-793887 is a CDK inhibitor that targets CDK2, CDK5, and CDK9. By blocking CDK-mediated phosphorylation and transcription, it arrests the cell cycle, suppresses cell proliferation, and induces apoptosis in cancer cells. | ||||||
P276-00 | 920113-03-7 | sc-477932 | 1 mg | $380.00 | ||
P276-00 is a CDK inhibitor that targets CDK1, CDK2, and CDK4. It disrupts cell cycle progression and induces apoptosis by inhibiting CDK-mediated phosphorylation, ultimately suppressing cell proliferation in various cancer types. | ||||||